Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Препарат Газива® станет доступен для терапии пациентов с хроническим лимфоцитарным лейкозом
Препарат Газива® станет доступен для терапии пациентов с хроническим лимфоцитарным лейкозом
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Новый препарат компании «Рош» Газива® (обинутузумаб) для терапии ранее не леченных пациентов станет доступен на российском рынке с сентября 2015 г.
Полный текст
Список литературы
1. Goede V et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. NEJM 2014; 370: 1101–10. Doi:10.1056/NEJMoa1313984
2. Lamanna N et al. Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia. Cancer Management. Available at: http://www.cancernetwork.com/cancer-management/chronic-lymphocytic-leukemia-and-hairy-cell-leukemia
3. Ferlay J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (6): 1374–403. Doi: 10.1016/j.ejca.2012.12.027
4. GLOBOCAN Europe (2012). Estimate cancer incidence, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
5. LOBOCAN Europe (2012). Estimate cancer mortality, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
6. Goede V et al. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. Leukemia 2015: 1–3. Doi:10.1038/leu.2015.14
2. Lamanna N et al. Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia. Cancer Management. Available at: http://www.cancernetwork.com/cancer-management/chronic-lymphocytic-leukemia-and-hairy-cell-leukemia
3. Ferlay J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (6): 1374–403. Doi: 10.1016/j.ejca.2012.12.027
4. GLOBOCAN Europe (2012). Estimate cancer incidence, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
5. LOBOCAN Europe (2012). Estimate cancer mortality, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
6. Goede V et al. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. Leukemia 2015: 1–3. Doi:10.1038/leu.2015.14
2. Lamanna N et al. Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia. Cancer Management. Available at: http://www.cancernetwork.com/cancer-management/chronic-lymphocytic-leukemia-and-hairy-cell-leukemia
3. Ferlay J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (6): 1374–403. Doi: 10.1016/j.ejca.2012.12.027
4. GLOBOCAN Europe (2012). Estimate cancer incidence, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
5. LOBOCAN Europe (2012). Estimate cancer mortality, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
6. Goede V et al. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. Leukemia 2015: 1–3. Doi:10.1038/leu.2015.14
________________________________________________
2. Lamanna N et al. Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia. Cancer Management. Available at: http://www.cancernetwork.com/cancer-management/chronic-lymphocytic-leukemia-and-hairy-cell-leukemia
3. Ferlay J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49 (6): 1374–403. Doi: 10.1016/j.ejca.2012.12.027
4. GLOBOCAN Europe (2012). Estimate cancer incidence, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
5. LOBOCAN Europe (2012). Estimate cancer mortality, all ages: both sexes. Available at: http://globocan.iarc.fr/old/summary_table_pop-html.asp?selection=62968&title=Europe&...
6. Goede V et al. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study. Leukemia 2015: 1–3. Doi:10.1038/leu.2015.14
Авторы
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.